NFC
GSK icon

Northeast Financial Consultants’s GSK GSK Stock Holding History

Northeast Financial Consultants’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$505K Buy
+13,160
New +$503K 0.02% 204
2023
Q1 		– Sell
-10,324
Closed -$363K – 322
2022
Q4 		$363K Buy
10,324
+300
+3% +$9.99K 0.02% 223
2022
Q3 		$295K Buy
+10,024
New +$380K 0.02% 264

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Northeast Financial Consultants's GSK Position: Q2 2025 in Review

Northeast Financial Consultants opened a new position in GSK (GSK) in Q2 2025: 13,160 shares worth $505K. The stake represents 0.02% of the portfolio and ranks #204 among its holdings. This is a return to the name: Northeast Financial Consultants previously reported a position in GSK as recently as Q4 2022.

Northeast Financial Consultants first reported a position in GSK in Q3 2022 and has held it in 3 quarters since. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Northeast Financial Consultants held 13,160 shares of GSK worth $505K as of Q2 2025.
  • GSK was a new Northeast Financial Consultants position in Q2 2025.
  • GSK made up 0.02% of Northeast Financial Consultants's portfolio in Q2 2025, its #204 holding.
  • Northeast Financial Consultants first reported a position in GSK in Q3 2022 and has held it in 3 quarters since.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.